Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Langford IC Systems is a specialized medical technology company focused on the development and manufacture of advanced drug delivery devices for inhaled therapies. The company's flagship product, the Langford IC (In-Circuit) system, is designed to facilitate the administration of metered-dose inhaler (MDI) medications directly into breathing circuits without interrupting airflow or breaking the circuit. This technology is utilized in both human critical care settings and veterinary medicine to treat acute respiratory conditions such as asthma and COPD in ventilated patients. By maintaining circuit integrity, the system improves dosing accuracy, enhances patient safety, and reduces the risk of environmental contamination in clinical environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Langford IC Systems.